Filing Details

Accession Number:
0001140361-10-049581
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-14 17:22:30
Reporting Period:
2010-12-10
Filing Date:
2010-12-14
Accepted Time:
2010-12-14 17:22:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124105 Targacept Inc TRGT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295831 Merouane Bencherif C/O Targacept, Inc.
200 East First Street, Suite 300
Winston-Salem NC 27101
Svp, Preclinical Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-10 7,194 $5.55 7,194 No 4 M Direct
Common Stock Acquisiton 2010-12-10 14,275 $8.51 21,469 No 4 M Direct
Common Stock Acquisiton 2010-12-10 10,624 $2.93 32,093 No 4 M Direct
Common Stock Disposition 2010-12-10 32,093 $24.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-12-10 7,194 $0.00 7,194 $5.55
Common Stock Stock Option (Right to Buy) Disposition 2010-12-10 14,275 $0.00 14,275 $8.51
Common Stock Stock Option (Right to Buy) Disposition 2010-12-10 10,624 $0.00 10,624 $2.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,751 2016-08-15 No 4 M Direct
14,280 2017-12-18 No 4 M Direct
23,908 2019-01-08 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. This option vested in installments and became vested and exercisable in full on June 30, 2010.
  3. This option vested (vests) in equal installments on the last day of 16 consecutive calendar quarters begininng with December 31, 2007.
  4. This option vested (vests) in equal installments on the last day of 16 consecutive calendar quarters begininng with March 31, 2009.